BlackRock »

Ocular Therapeutix shares owned by BlackRock

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $99M 11M 8.70

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
Deep Track Capital
BlackRock
BlackRock
Vanguard Group
TCG Crossover Management
Logos Global Management
Opaleye Management
Citadel Advisors
State Street Corporation
Perceptive Advisors
Geode Capital Management
Assenagon Asset Management
Deltec Asset Management

View all funds holding Ocular Therapeutix